chronic atrophic gastritis
Conditions
Interventions
Wei Yin deficiency:Modified Yiguanjian Single Herbal Concentrate-granules+Vitacoenzyme Tablets placebo
clinical group of Spleen-stomach deficiency:Modified Xiangsha liujunzi Single Herbal Concentrate-granules+Vitacoenzyme Tablets placebo
control group of Spleen-stomach deficiency:Vitacoenzyme Tablets+Modified Xiangsha liujunzi Single Herbal Concentrate-granules placebo
clinical group of Qi deficiency and heat-stasis:Renzhu jianwei Single Herbal Concentrate-granules+Vitacoenzyme Tablets placebo
control group of Qi deficiency and heat-stasis:Vitacoenzyme Tablets+Renzhu jianwei Single Herbal Concentrate-granules placebo
Gan Wei Incoordination:Modified Chaihushugan Single Herbal Concentrate-granules+Vitacoenzyme Tablets placebo
Ganwei Incoordination control:Vitacoenzyme Tablets+Modified Chaihushugan Single Herbal Concentrate-granules placebo
Sponsors
Jiangsu Province Hospital on Integration of Chinese and Western Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. chronic atrophic gastritis confirmed via endoscopy and biopsy within one month prior to the trial; 2. age of 18-65 years; 3.not taking related medication within a week; 4. voluntarily signed informed consent.
Exclusion criteria
Exclusion criteria: 1. severe hyperplasia of the stomach mucosa or malignant pathological changes; 2. age below 18 or above 65 years old; 3. severe primary diseases of heart, liver, kidney and blood systems, and psychosis; 4. Pregnancy or prepare pregnant women, or lactation; 5. allergic constitution or allergy to experiment drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gastroscope and pathology;symptom score; | — |
Countries
China
Contacts
Public ContactZhu Fangshi
Jiangsu Province Hospital on Integration of Chinese and Western Medicine
Outcome results
None listed